KIT and neoplasm: For example, sunitinib inhibits a number of growth factor receptors regulating both tumor cell proliferation/survival and tumor angiogenesis including vascular endothelial growth factor receptors, platelet-derived growth factor receptors α and β, c-Kit, FLT3, CSF1R, and RET [66].